Candida albicans and Non-C. albicans Candida Species: Comparison of Biofilm Production and Metabolic Activity in Biofilms, and Putative Virulence Properties of Isolates from Hospital Environments and Infections

Mycopathologia

Volumn 175, Issue 3-4, 2013, Pages 265-272

  Ferreira, A V ^a   Prado, C G ^a   Carvalho, R R ^a   Dias, K S T ^a   Dias, A L T ^a  

^a FEDERAL UNIVERSITY OF ALFENAS   (Brazil)

Author keywords

Antifungals; Biofilm; Candida spp.; Hemolysin; Hospital environments; Virulence

Indexed keywords

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 84876096414     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-013-9638-z     Document Type: Article

References (34)

1. Nunn MA, Schäfer SM, Petrou MA. Enviromental source of Candida dubliniensis. Emerg Infect Dis. 2007; 13: 747-50.
2. Traore O, Springthorpe VS, Sattar SA. A quantitative study of the survival of two species of Candida on porous and non-porous environmental surfaces and hands. J Appl Microbiol. 2002; 92: 549-55.
3. Passos XS, Sales WS, Maciel PJ, et al. Candida colonization in intensive care unit patients' urine. Mem Inst Oswaldo Cruz. 2005; 100: 925-8.
4. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infections? Clin Infect Dis. 2004; 39: 1182-9.
5. Osorio JJC, Rivero A, Cisneros JT. Epidemiology of invasive fungal infection. J Antimicrob Agents. 2008; 32: 103-9.
6. Tamura NK, Negri MFN, Bonassoli LA, Svidzinski TIE. Virulence factors for Candida spp. recovered from intravascular catheters and hospital workers' hands. Rev Soc Bras Med Trop. 2007; 40: 91-3.
7. Kung HC, Wang JL, Chang SC, et al. Community-onset candidemia at a university hospital, 1995-2005. J Microbiol Immunol Infect. 2007; 40: 355-63.
8. Pappas PG, Rex JH, Lee J, et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin Infect Dis. 2003; 37: 634-43.
9. Colombo AL, Nakagawa Z, Valdetaro F, et al. Susceptibility profile of 200 bloodstream isolates of Candida species collected from Brazilian tertiary care hospitals. Med Mycol. 2003; 41: 235-9.
10. Kurtzman CP, Fell JW. The yeasts, a taxonomic study. 4th ed. Amsterdam: Elsevier; 1998.
11. Gales AC, Pfaller MA, Houston AK, et al. Identification of Candida dubliniensis based on temperature and utilization of xylose and α-methyl-d-glucoside as determined with the API 20C AUX and Vitek YBC systems. J Clin Microbiol. 1999; 37: 3804-8.
12. Shin JH, Kee SJ, Shin MG, et al. Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of blood stream isolates with isolates from other sources. J Clin Microbiol. 2002; 40: 1244-8.
13. Kuhn DM, Chandra J, Mukherjee PK, Ghannoum MA. Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun. 2002; 70: 878-88.
14. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. Candida biofilms: an update. Eukaryot Cell. 2005; 4: 633-8.
15. Luo G, Samaranayake LP, Yau JYY. Candida Species exhibit differential in vitro hemolytic activities. J Clin Microbiol. 2001; 39: 2971-4.
16. CLSI. Reference method for antifungal disk diffusion susceptibility testing of yeasts. Approved guideline-2nd ed. CLSI document M44-A2. Wayne: Clinical and Laboratory Standards Institute; 2009.
17. CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard-3rd ed. CLSI document M27-A3. Wayne: Clinical and Laboratory Standards Institute; 2008.
18. Crump JA, Collignon PJ. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis. 2000; 19: 1-8.
19. Andes D, Nett J, Albrecht R, et al. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun. 2004; 72: 6023-31.
20. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004; 17: 255-67.
21. Colombo A, Guimarães T. Epidemiology of hematogenous infections due to Candida spp. Rev Soc Bras Med Trop. 2003; 36: 599-607.
22. Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun. 1994; 62: 5154-6.
23. Bullen JJ. The significance of iron in infection. Rev Infect Dis. 1981; 3: 1127-38.
24. França EJG, Furlaneto-Maia L, Quesada RMB, Oliveira MT, Furlaneto MC. Hemolytic and proteinase activities in clinical isolates of Candida parapsilosis and Candida tropicalis with reference to the isolation anatomic site. Mycoses. 2010; 54: 44-51.
25. Ramage G, Martínez JP, López-Ribot JL. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 2006; 6: 979-86.
26. Nett J, Andes D. Candida albicans biofilm development, modeling a host-pathogen interaction. Curr Opin Microbiol. 2006; 9: 340-5.
27. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol. 2003; 11: 30-6.
28. Bachmann SP, Ramage G, VandeWalle K, et al. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother. 2003; 47: 3657-9.
29. Hasan F, Xess I, Wang X, Jain N, Fries BC. Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect. 2009; 11: 753-61.
30. Mishra NN, Prasad T, Sharma N, et al. Pathogenicity and drug resistance in Candida albicans and other yeast species. Acta Microbiol Immunol Hung. 2007; 54: 201-35.
31. Estivill D, Arias A, Torres-Lana A, Carrillo-Muñoz AJ, Arévalo MP. Biofilm formation by five species of Candida on three clinical materials. J Microbiol Methods. 2011; 86: 238-42.
32. Mohandas V, Ballal M. Distribution of Candida species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in southern India. J Glob Infect Dis. 2011; 3: 4-8.
33. Silva S, Henriques M, Oliveira R, Williams D, Azeredo J. In vitro biofilm activity of non-Candida albicans Candida Species. Curr Microbiol. 2010; 61: 534-40.
34. França JCB, Ribeiro CEL, Queiroz-Telles F. Candidemia in a Brazilian tertiary care hospital: incidence, frequency of different species, risk factors and antifungal susceptibility. Rev Soc Bras Med Trop. 2008; 41: 23-8.